Other OTC - Delayed Quote • USD
Global Pharmatech, Inc. (GBLP)
At close: February 27 at 3:07 PM EST
Breakdown
TTM
Total Revenue
3,179.5090
Cost of Revenue
1,709.2980
Gross Profit
1,470.2110
Operating Expense
26,203.7490
Operating Income
-24,733.5380
Other Income Expense
260.6920
Net Income Common Stockholders
-3,044.6330
Diluted NI Available to Com Stockholders
-3,044.6330
Basic EPS
-0.09
Diluted EPS
-0.09
Basic Average Shares
23,247.9350
Diluted Average Shares
23,247.9350
Total Operating Income as Reported
-24,733.5380
Total Expenses
27,913.0470
Net Income from Continuing & Discontinued Operation
-3,044.6330
Normalized Income
-2,455.1039
Interest Expense
234.5930
Net Interest Income
-234.5930
EBIT
-24,733.5380
EBITDA
-24,240.2590
Reconciled Cost of Revenue
1,709.2980
Reconciled Depreciation
493.2790
Net Income from Continuing Operation Net Minority Interest
-2,240.0330
Total Unusual Items Excluding Goodwill
260.6920
Total Unusual Items
260.6920
Normalized EBITDA
-24,500.9510
Tax Rate for Calcs
0.0002
Tax Effect of Unusual Items
45.6211
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CPIX Cumberland Pharmaceuticals Inc.
1.7600
+7.65%
AKAN Akanda Corp.
0.1030
+12.57%
EVOK Evoke Pharma, Inc.
0.4580
+2.92%
PRFX PainReform Ltd.
0.8101
-2.40%
BFRI Biofrontera Inc.
1.5900
-7.02%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3850
-0.90%
CLVR Clever Leaves Holdings Inc.
4.1100
+0.98%
CPHI China Pharma Holdings, Inc.
0.3023
-7.27%
AGRX Agile Therapeutics, Inc.
0.4000
0.00%
CYTH Cyclo Therapeutics, Inc.
1.2600
-5.26%